Business

CONMED Corporation Announces Chief Financial Officer Transition

LARGO, Fla., January 08, 2026--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026.

articleConmed CorporationJanuary 8, 20263/company/conmed-corporation/news/conmed-corporation-announces-chief-financial-215500645
CONMED Corporation Announces Chief Financial Officer Transition

About this update from Conmed Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1518,"height":285,"url":"https://media.zenfs.com/en/business-wire.com/5a022f617a8f6902be24a07b0340574c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GPjaQ6oR__KxBKvzCRoY0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5a022f617a8f6902be24a07b0340574c","width":960,"height":180},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/p3aGlQ30ylDuYMeLwDb_hw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NTA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/5a022f617a8f6902be24a07b0340574c","width":1200,"height":225}},"lazy":false},{"type":"text","content":"Todd Garner to step down as CONMED’s CFO, effective March 15, 2026, and remain In an Advisory Role Through November 2, 2026","length":123,"tagName":"p","attribs":{}},{"type":"text","content":"Company Initiates Comprehensive Search for Next Chief Financial Officer","length":71,"tagName":"p","attribs":{}},{"type":"text","content":"CONMED Reaffirms Full-Year 2025 Revenue and Adjusted EPS Outlook","length":64,"tagName":"p","attribs":{}},{"type":"text","content":"LARGO, Fla., January 08, 2026--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026.","length":324,"tagName":"p"},{"type":"text","content":"CONMED has initiated a comprehensive search process, supported by a leading executive search firm, to identify its next Chief Financial Officer.","length":144,"tagName":"p"},{"type":"text","content":""On behalf of our Board and leadership team, I want to thank Todd for his many contributions to CONMED over the past eight years," said Pat Beyer, President and Chief Executive Officer. "Todd has been instrumental in strengthening our financial foundation and supporting strategic initiatives that position CONMED for scalable, long-term growth. We are also grateful for his commitment to ensuring a seamless transition."","length":441,"tagName":"p"},{"type":"text","content":""I am grateful to my CONMED colleagues over the past eight years. It has been rew...

More updates from Conmed Corporation

CONMED CorporationTodd GarnerChief Executive OfficerForward-Looking Statementsthe companyCONMEDCompany